Friday, September 20, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

CDC Opts for mRNA Biologics Over J&J COVID Vaccine Following Nine Blood Clotting Deaths

blood clotting

Based on concerns over a growing number of reports of a blood clotting disorder known as thrombosis with thrombocytopenia syndrome (TTS) following vaccination with Johnson & Johnson/Janssen’s experimental human adenovirus vectored Ad26.COV2.S vaccine, the Advisory Committee on Immunization Practices (ACIP) voted 15-0 on Dec. 16, 2021 to recommend the experimental messenger RNA (mRNA) COVID-19 biologics […]

Ohio Jury Found Pharmacies Liable for Fueling the Opioid Crisis

opioid crisis

On Nov. 23, 2021, a federal jury in Ohio held pharmacies liable for their role in the epidemic of opioid use in America. The jury found that CVS, Walgreens and Walmart were responsible for inappropriately dispensing large amounts of opioid drugs prescribed by doctors that caused hundreds of deaths from overdoses. Rite Aid and Giant […]

Some Physicians Warn Against Warp Speed COVID Vaccinations for Children

little girl vaccinated for COVID

On Oct. 29, 2021 the U.S Food and Drug Administration (FDA) approved the use of Pfizer/BioNTech COVID-19 vaccine by five- to 11-year-old children under federal Emergency Use Authorization (EUA) guidelines. As California became the first state to announce that COVID vaccine will be required for children to attend school, districts in several other states plan […]

Merck and Pfizer Seek Approval for COVID-19 Antiviral Drugs

Merck's antiviral drug Molnupiravir

Merck and Pfizer have submitted Emergency Use Authorization (EUA) applications to the U.S. Food and Drug Administration (FDA) to authorize distribution of what would be the first antiviral drug specifically designed to treat COVID-19 disease.1 Merck/Ridgeback Biotherapeutics are seeking EUA approval for Molnupiravir (MK-4482/EIDD-2801), an investigational oral antiviral drug originally developed to treat influenza.2 Pfizer […]

FDA, CDC Green Light Pfizer’s Experimental COVID Biologic for Children 5 to 11 Years Old

child getting vaccinated

One Oct 29, 2021, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the experimental messenger RNA (mRNA) Pfizer/BioNTech COVID-19 biologic BNT162b2 for children five to 11 years old. The FDA’s decision, which is based on a clinical trial earlier this year involving 2,268 kindergartners and elementary school-aged kids and an […]

Search in Site

To search in site, type your keyword and hit enter